10-73911598-G-A

Variant summary

Our verdict is Uncertain significance. The variant received 0 ACMG points: 2P and 2B. PM2BP4_Moderate

The NM_001145031.3(PLAU):​c.-294G>A variant causes a 5 prime UTR premature start codon gain change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000131 in 152,222 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: 𝑓 0.000013 ( 0 hom., cov: 32)

Consequence

PLAU
NM_001145031.3 5_prime_UTR_premature_start_codon_gain

Scores

1
3
12

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: 0.995

Publications

13 publications found
Variant links:
Genes affected
PLAU (HGNC:9052): (plasminogen activator, urokinase) This gene encodes a secreted serine protease that converts plasminogen to plasmin. The encoded preproprotein is proteolytically processed to generate A and B polypeptide chains. These chains associate via a single disulfide bond to form the catalytically inactive high molecular weight urokinase-type plasminogen activator (HMW-uPA). HMW-uPA can be further processed into the catalytically active low molecular weight urokinase-type plasminogen activator (LMW-uPA). This low molecular weight form does not bind to the urokinase-type plasminogen activator receptor. Mutations in this gene may be associated with Quebec platelet disorder and late-onset Alzheimer's disease. Alternative splicing results in multiple transcript variants, at least one of which encodes an isoform that is proteolytically processed. [provided by RefSeq, Jan 2016]
C10orf55 (HGNC:31008): (chromosome 10 putative open reading frame 55) Enables identical protein binding activity. [provided by Alliance of Genome Resources, Apr 2022]

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Uncertain_significance. The variant received 0 ACMG points.

PM2
Very rare variant in population databases, with high coverage;
BP4
Computational evidence support a benign effect (MetaRNN=0.24634475).

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_001145031.3. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
PLAU
NM_002658.6
MANE Select
c.43G>Ap.Val15Met
missense
Exon 2 of 11NP_002649.2P00749-1
PLAU
NM_001145031.3
c.-294G>A
5_prime_UTR_premature_start_codon_gain
Exon 2 of 10NP_001138503.2P00749-2
PLAU
NM_001319191.2
c.-188G>A
5_prime_UTR_premature_start_codon_gain
Exon 2 of 10NP_001306120.2

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
PLAU
ENST00000372764.4
TSL:1 MANE Select
c.43G>Ap.Val15Met
missense
Exon 2 of 11ENSP00000361850.3P00749-1
C10orf55
ENST00000409178.5
TSL:1
n.884C>T
non_coding_transcript_exon
Exon 5 of 5
PLAU
ENST00000446342.5
TSL:2
c.-294G>A
5_prime_UTR_premature_start_codon_gain
Exon 2 of 10ENSP00000388474.1P00749-2

Frequencies

GnomAD3 genomes
AF:
0.0000131
AC:
2
AN:
152222
Hom.:
0
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.0000241
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.0000147
Gnomad OTH
AF:
0.00
GnomAD4 exome
Cov.:
32
GnomAD4 genome
AF:
0.0000131
AC:
2
AN:
152222
Hom.:
0
Cov.:
32
AF XY:
0.0000134
AC XY:
1
AN XY:
74362
show subpopulations
African (AFR)
AF:
0.0000241
AC:
1
AN:
41450
American (AMR)
AF:
0.00
AC:
0
AN:
15288
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3472
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5196
South Asian (SAS)
AF:
0.00
AC:
0
AN:
4832
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10620
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
316
European-Non Finnish (NFE)
AF:
0.0000147
AC:
1
AN:
68042
Other (OTH)
AF:
0.00
AC:
0
AN:
2094
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.525
Heterozygous variant carriers
0
0
1
1
2
2
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00
Hom.:
39
Bravo
AF:
0.00000378

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.14
BayesDel_addAF
Uncertain
0.034
T
BayesDel_noAF
Benign
-0.19
CADD
Benign
17
DANN
Benign
0.96
Eigen
Benign
-0.048
Eigen_PC
Benign
-0.16
FATHMM_MKL
Benign
0.17
N
LIST_S2
Benign
0.63
T
M_CAP
Benign
0.060
D
MetaRNN
Benign
0.25
T
MetaSVM
Uncertain
-0.21
T
PhyloP100
0.99
PrimateAI
Benign
0.47
T
PROVEAN
Benign
-0.16
N
REVEL
Benign
0.25
Sift
Uncertain
0.029
D
Sift4G
Pathogenic
0.0
D
Vest4
0.40
MutPred
0.28
Loss of sheet (P = 0.0315)
MVP
0.94
MPC
0.28
ClinPred
0.67
D
GERP RS
2.8
PromoterAI
0.0094
Neutral
gMVP
0.44
Mutation Taster
=98/2
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs2227580; hg19: chr10-75671356; API